These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35387168)

  • 1. Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening.
    Dong H; Li Z; Bian S; Song G; Song W; Zhang M; Xie H; Zheng S; Yang X; Li T; Song P
    Bioact Mater; 2022 Dec; 18():164-177. PubMed ID: 35387168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
    Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY
    Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.
    Grützmeier SE; Kovacevic B; Vilmann P; Rift CV; Melchior LC; Holmström MO; Brink L; Hassan H; Karstensen JG; Grossjohann H; Chiranth D; Toxværd A; Hansen CP; Høgdall E; Hasselby JP; Klausen P
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer.
    Martini G; Belli V; Napolitano S; Ciaramella V; Ciardiello D; Belli A; Izzo F; Avallone A; Selvaggi F; Menegon Tasselli F; Santaniello W; Franco R; Puig I; Ramirez L; Chicote I; Mancuso F; Caratu G; Serres X; Fasani R; Jimenez J; Ros J; Baraibar I; Mulet N; Della Corte CM; Troiani T; Vivancos A; Dienstmann R; Elez E; Palmer HG; Tabernero J; Martinelli E; Ciardiello F; Argilés G
    ESMO Open; 2023 Jun; 8(3):101198. PubMed ID: 37119788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogel-based colorectal cancer organoid co-culture models.
    Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
    Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.
    Charpentier M; Bloy N; Formenti SC; Galluzzi L; Demaria S
    J Vis Exp; 2024 Apr; (206):. PubMed ID: 38647326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The landscape of drug sensitivity and resistance in sarcoma.
    Al Shihabi A; Tebon PJ; Nguyen HTL; Chantharasamee J; Sartini S; Davarifar A; Jensen AY; Diaz-Infante M; Cox H; Gonzalez AE; Swearingen S; Tavanaie N; Dry S; Singh A; Chmielowski B; Crompton JG; Kalbasi A; Eilber FC; Hornicek F; Bernthal N; Nelson SD; Boutros PC; Federman N; Yanagawa J; Soragni A
    bioRxiv; 2023 Aug; ():. PubMed ID: 37292676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation patient derived tumor organoids.
    Podaza E; Kuo HH; Nguyen J; Elemento O; Martin ML
    Transl Res; 2022 Dec; 250():84-97. PubMed ID: 35964899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Organoids: The Era of Personalized Medicine.
    Rassomakhina NV; Ryazanova AY; Likhov AR; Bruskin SA; Maloshenok LG; Zherdeva VV
    Biochemistry (Mosc); 2024 Jan; 89(Suppl 1):S127-S147. PubMed ID: 38621748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
    Tan T; Mouradov D; Gibbs P; Sieber OM
    STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment.
    Vivarelli S; Candido S; Caruso G; Falzone L; Libra M
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer.
    van der Graaff D; Seghers S; Vanclooster P; Deben C; Vandamme T; Prenen H
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response.
    Kim S; Choung S; Sun RX; Ung N; Hashemi N; Fong EJ; Lau R; Spiller E; Gasho J; Foo J; Mumenthaler SM
    SLAS Discov; 2020 Aug; 25(7):744-754. PubMed ID: 32349587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues.
    Takahashi Y; Morimura R; Tsukamoto K; Gomi S; Yamada A; Mizukami M; Naito Y; Irie S; Nagayama S; Shinozaki E; Yamaguchi K; Fujita N; Kitano S; Katayama R; Matsusaki M
    Acta Biomater; 2024 Jul; 183():111-129. PubMed ID: 38801868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology.
    Thorel L; Perréard M; Florent R; Divoux J; Coffy S; Vincent A; Gaggioli C; Guasch G; Gidrol X; Weiswald LB; Poulain L
    Exp Mol Med; 2024 Jul; 56(7):1531-1551. PubMed ID: 38945959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the functional roles of patient-derived tumour organoids in assessing the tumour microenvironment and immunotherapy.
    Chen D; Xu L; Xuan M; Chu Q; Xue C
    Clin Transl Med; 2024 Sep; 14(9):e1802. PubMed ID: 39245957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
    Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of drug sensitivity and resistance in sarcoma.
    Al Shihabi A; Tebon PJ; Nguyen HTL; Chantharasamee J; Sartini S; Davarifar A; Jensen AY; Diaz-Infante M; Cox H; Gonzalez AE; Norris S; Sperry J; Nakashima J; Tavanaie N; Winata H; Fitz-Gibbon ST; Yamaguchi TN; Jeong JH; Dry S; Singh AS; Chmielowski B; Crompton JG; Kalbasi AK; Eilber FC; Hornicek F; Bernthal NM; Nelson SD; Boutros PC; Federman NC; Yanagawa J; Soragni A
    Cell Stem Cell; 2024 Oct; 31(10):1524-1542.e4. PubMed ID: 39305899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework.
    Gunnarsson EB; Kim S; Choi B; Schmid JK; Kaura K; Lenz HJ; Mumenthaler SM; Foo J
    PLoS Comput Biol; 2024 Aug; 20(8):e1012256. PubMed ID: 39093897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutoff value of IC
    Tang Y; Wang T; Hu Y; Ji H; Yan B; Hu X; Zeng Y; Hao Y; Xue W; Chen Z; Lan J; Wang Y; Deng H; Deng C; Wu X; Yan J
    iScience; 2023 Jul; 26(7):107116. PubMed ID: 37426352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.